series-b
Stage
1
Investors
About
Cinclus Pharma is a clinical-stage pharmaceutical company developing small molecule drugs, specifically potassium-competitive acid blockers, for the treatment of gastric acid-related diseases such as gastroesophageal reflux disease (GERD) and Helicobacter Pylori infection.
Explore Cinclus Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.